tiprankstipranks
Trending News
More News >
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market

Cognition Therapeutics (CGTX) Financial Statements

Compare
587 Followers

Cognition Therapeutics Financial Overview

Cognition Therapeutics's market cap is currently $125.35M. The company's EPS TTM is $-0.06; its P/E ratio is -2.91; Cognition Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -252.00K$ -235.00K$ 0.00$ -98.00K
Operating Income$ -53.97M$ -50.72M$ -43.55M$ -28.60M$ -17.41M
EBITDA$ -33.68M$ -25.51M$ -21.13M$ -10.73M$ -5.99M
Net Income$ -33.97M$ -25.79M$ 757.00K$ -11.72M$ -10.07M
Balance Sheet
Cash & Short-Term Investments$ 25.01M$ 29.92M$ 41.56M$ 54.72M$ 5.19M
Total Assets$ 30.23M$ 35.16M$ 50.42M$ 59.14M$ 7.12M
Total Debt$ 814.00K$ 1.24M$ 1.48M$ 0.00$ 12.85M
Net Debt$ -24.20M$ -28.68M$ -40.08M$ -54.72M$ 7.66M
Total Liabilities$ 11.48M$ 10.69M$ 10.18M$ 7.86M$ 75.30M
Stockholders' Equity$ 18.75M$ 24.47M$ 40.25M$ 51.27M$ -68.18M
Cash Flow
Free Cash Flow$ -28.48M$ -16.16M$ -18.70M$ -3.66M$ -3.44M
Operating Cash Flow$ -28.47M$ -16.02M$ -18.53M$ -3.63M$ -3.43M
Investing Cash Flow$ -4.00K$ -147.00K$ -171.00K$ -27.00K$ -10.00K
Financing Cash Flow$ 23.57M$ 4.52M$ 5.55M$ 53.20M$ 5.76M
Currency in USD

Cognition Therapeutics Earnings and Revenue History

Cognition Therapeutics Debt to Assets

Cognition Therapeutics Cash Flow

Cognition Therapeutics Forecast EPS vs Actual EPS